UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population

The Annals of pharmacotherapy, 2016-08, Vol.50 (8), p.673-679

2016

Volltextzugriff (PDF)

High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy

Antimicrobial agents and chemotherapy, 2017-02, Vol.61 (2)

2017

Volltextzugriff (PDF)

Diagnosis and management of Pneumocystis jirovecii infection

Expert review of anti-infective therapy, 2017-05, Vol.15 (5), p.435-447

2017

Volltextzugriff (PDF)

Deep mutational scanning of Pneumocystis jirovecii dihydrofolate reductase reveals allosteric mechanism of resistance to an antifolate

PLoS genetics, 2024-04, Vol.20 (4), p.e1011252-e1011252

2024

Volltextzugriff (PDF)

ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients

Journal of antimicrobial chemotherapy, 2016-09, Vol.71 (9), p.2405-2413

2016

Volltextzugriff (PDF)

Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review

Expert review of anti-infective therapy, 2017-09, Vol.15 (9), p.873-892

2017

Volltextzugriff (PDF)

High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia

International journal of infectious diseases, 2019-11, Vol.88, p.141-148

2019

Volltextzugriff (PDF)

Site-Directed Mutagenesis of the 1,3-β-Glucan Synthase Catalytic Subunit of Pneumocystis jirovecii and Susceptibility Assays Suggest Its Sensitivity to Caspofungin

Antimicrobial agents and chemotherapy, 2018-12, Vol.62 (12)

2018

Volltextzugriff (PDF)

The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus‐negative immunocompromised patients: A systematic review

Transplant infectious disease, 2017-04, Vol.19 (2), p.n/a

2017

Volltextzugriff (PDF)

Chloroquine Analogues as Leads against Pneumocystis Lung Pathogens

Antimicrobial agents and chemotherapy, 2018-11, Vol.62 (11)

2018

Volltextzugriff (PDF)

Deciphering Antifungal Drug Resistance in Pneumocystis jirovecii DHFR with Molecular Dynamics and Machine Learning

Journal of chemical information and modeling, 2021-06, Vol.61 (6), p.2537-2541

2021

Volltextzugriff (PDF)

Clinical applications of pulmonary delivery of antibiotics

Advanced drug delivery reviews, 2015-05, Vol.85, p.1-6

2015

Volltextzugriff (PDF)

Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia

Emerging infectious diseases, 2013-01, Vol.19 (1), p.21-28

2013

Volltextzugriff (PDF)

Trimethoprim Resistance of Dihydrofolate Reductase Variants from Clinical Isolates of Pneumocystis jirovecii

Antimicrobial Agents and Chemotherapy, 2013-10, Vol.57 (10), p.4990-4998

2013

Volltextzugriff (PDF)

Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study

Annals of clinical microbiology and antimicrobials, 2021-11, Vol.20 (1), p.78-7, Article 78

2021

Volltextzugriff (PDF)

Outcomes of Moderate-to-Severe Pneumocystis Pneumonia Treated with Adjunctive Steroid in Non-HIV-Infected Patients

Antimicrobial Agents and Chemotherapy, 2011-10, Vol.55 (10), p.4613-4618

2011

Volltextzugriff (PDF)

Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia

PloS one, 2014-09, Vol.9 (9), p.e106141

2014

Volltextzugriff (PDF)

Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients—difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019-11, Vol.25 (11), p.920-924

2019

Volltextzugriff (PDF)

Analysis of current antifungal agents and their targets within the Pneumocystis carinii genome

Current drug targets, 2012-11, Vol.13 (12), p.1575-1585

2012

Volltextzugriff (PDF)

Characterization of Pneumocystis jirovecii pneumonia at three tertiary comprehensive hospitals in southern China

Brazilian journal of microbiology, 2020-09, Vol.51 (3), p.1061-1069

2020

Volltextzugriff (PDF)

Scalable Preparation and Differential Pharmacologic and Toxicologic Profiles of Primaquine Enantiomers

Antimicrobial agents and chemotherapy, 2014-08, Vol.58 (8), p.4737-4744

2014

Volltextzugriff (PDF)

Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?

Rheumatology international, 2021-08, Vol.41 (8), p.1419-1427

2021

Volltextzugriff (PDF)

Aerodigestive adverse effects during intravenous pentamidine infusion for Pneumocystis jirovecii pneumonia prophylaxis

Pediatric blood & cancer, 2021-01, Vol.68 (1), p.e28714-n/a

2021

Volltextzugriff (PDF)

Cost-effectiveness analysis of diagnostic options for pneumocystis pneumonia (PCP)

PloS one, 2011-08, Vol.6 (8), p.e23158-e23158

2011

Volltextzugriff (PDF)

Post-diagnostic kinetics of the (1 → 3)-β-d-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia

Clinical microbiology and infection, 2012-05, Vol.18 (5), p.E122-E127

2012

Volltextzugriff (PDF)

1 – 25 von 871

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(782)
Mit Volltextzugriff
(672)

Publikationsform

Artikel
(865)
magazinearticle
(6)

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(721)
Humans
(718)
Life Sciences & Biomedicine
(706)
Pneumocystis Carinii
(533)
Male
(446)
Female
(369)
Biological And Medical Sciences
(351)
Pneumonia, Pneumocystis - Drug Therapy
(346)
Medical Sciences
(339)
Adult
(318)
Middle Aged
(298)
Infectious Diseases
(251)
Pharmacology. Drug Treatments
(238)
Aids/hiv
(184)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(173)
Aged
(171)
Microbiology
(171)
Pneumonia, Pneumocystis - Prevention & Control
(170)
Pneumonia
(165)
Animals
(162)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population

High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy

Diagnosis and management of Pneumocystis jirovecii infection

Deep mutational scanning of Pneumocystis jirovecii dihydrofolate reductase reveals allosteric mechanism of resistance to an antifolate

ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients

Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review

High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia

Site-Directed Mutagenesis of the 1,3-β-Glucan Synthase Catalytic Subunit of Pneumocystis jirovecii and Susceptibility Assays Suggest Its Sensitivity to Caspofungin

The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus‐negative immunocompromised patients: A systematic review

Chloroquine Analogues as Leads against Pneumocystis Lung Pathogens

Deciphering Antifungal Drug Resistance in Pneumocystis jirovecii DHFR with Molecular Dynamics and Machine Learning

Clinical applications of pulmonary delivery of antibiotics

Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia

Trimethoprim Resistance of Dihydrofolate Reductase Variants from Clinical Isolates of Pneumocystis jirovecii

Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study

Outcomes of Moderate-to-Severe Pneumocystis Pneumonia Treated with Adjunctive Steroid in Non-HIV-Infected Patients

Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia

Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients—difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole

Analysis of current antifungal agents and their targets within the Pneumocystis carinii genome

Characterization of Pneumocystis jirovecii pneumonia at three tertiary comprehensive hospitals in southern China

Scalable Preparation and Differential Pharmacologic and Toxicologic Profiles of Primaquine Enantiomers

Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?

Aerodigestive adverse effects during intravenous pentamidine infusion for Pneumocystis jirovecii pneumonia prophylaxis

Cost-effectiveness analysis of diagnostic options for pneumocystis pneumonia (PCP)

Post-diagnostic kinetics of the (1 → 3)-β-d-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia

Suchergebnisse filtern